CA12 and carcinoma: Recently, Guerrini et al. reported the involvement of CA XII in TNBC progression through its crosstalk with hedgehog pathway [39]; therefore, given that RC44 is able to inhibit also this isoform, we believe that this molecule may be more helpful in the treatment of this aggressive carcinoma.